Ocular Therapeutix (OCUL) Accumulated Depreciation & Amortization (2016 - 2025)
Ocular Therapeutix (OCUL) has 12 years of Accumulated Depreciation & Amortization data on record, last reported at $23.6 million in Q4 2024.
- For Q4 2024, Accumulated Depreciation & Amortization rose 16.64% year-over-year to $23.6 million; the TTM value through Dec 2024 reached $23.6 million, up 16.64%, while the annual FY2024 figure was $23.6 million, 16.64% up from the prior year.
- Accumulated Depreciation & Amortization reached $23.6 million in Q4 2024 per OCUL's latest filing, up from $20.3 million in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $23.6 million in Q4 2024 and bottomed at $12.8 million in Q4 2020.
- Average Accumulated Depreciation & Amortization over 5 years is $17.8 million, with a median of $17.3 million recorded in 2022.
- Peak YoY movement for Accumulated Depreciation & Amortization: rose 27.62% in 2020, then rose 13.62% in 2022.
- A 5-year view of Accumulated Depreciation & Amortization shows it stood at $12.8 million in 2020, then increased by 18.93% to $15.2 million in 2021, then rose by 13.62% to $17.3 million in 2022, then rose by 17.26% to $20.3 million in 2023, then rose by 16.64% to $23.6 million in 2024.
- Per Business Quant database, its latest 3 readings for Accumulated Depreciation & Amortization were $23.6 million in Q4 2024, $20.3 million in Q4 2023, and $17.3 million in Q4 2022.